Human Genome Epidemiology Literature Finder
|
Records 1 - 6 (of 6 Records) |
| Query Trace: Hyperplasia and C4B[original query] |
|---|
| Polymorphic markers in MHC class II/III region: a study on Italian patients with myasthenia gravis. Journal of the neurological sciences 2001 Sep 190 (1-2): 11-6. Franciotta D, Cuccia M, Dondi E, Piccolo G, Cosi |
| The chimeric CYP21P/CYP21 gene and 21-hydroxylase deficiency. Journal of human genetics 2004 1 49 (2): 65-72. Lee Hsien-Hsiu |
| Linkage analysis of the C4A/C4B copy number variation and polymorphisms of the adjacent steroid 21-hydroxylase gene in a healthy population. Molecular immunology 2009 Aug 46 (13): 2623-9. Blaskó Bernadett, Bánlaki Zsófia, Gyapay Gabor, Pozsonyi Eva, Sasvári-Székely Mária, Rajczy Katalin, Füst George, Szilágyi Agn |
| Association between copy number variation of complement component C4 and Graves' disease. Journal of biomedical science 2011 18 (1): 71. Liu Yu-Huei, Wan Lei, Chang Chwen-Tzuei, Liao Wen-Ling, Chen Wen-Chi, Tsai Yuhsin, Tsai Chang-Hai, Tsai Fuu-J |
| A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Gene 2013 Sep 526 (2): 239-45. Coeli-Lacchini Fernanda Borchers, Turatti Wendy, Elias Paula Conde Lamparelli, Elias Lucila Leico Kagohara, Martinelli Carlos Eduardo, Moreira Ayrton Custodio, Antonini Sonir Roberto, de Castro Margar |
| Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Human genetics 2018 11 137 (11-12): 955-960. Lao Qizong, Jardin Marcia Des, Jayakrishnan Rahul, Ernst Monique, Merke Deborah |
- Page last reviewed:Feb 1, 2024
- Content source: